Circulating tumor DNA (ctDNA) and late recurrence in high-risk, hormone receptor–positive, HER2-negative breast cancer (CHiRP).
暂无分享,去创建一个
E. Winer | N. Lin | M. Hughes | Ashka Patel | S. Tolaney | R. McEwen | G. Kirkner | K. Howarth | E. D. de Bruin | I. Krop | H. Parsons | G. Marsico | C. Knape | D. Stetson | Katheryn Santos | U. Feger | M. Lipsyc-Sharf